CYNTHIA M BUTITTA
CIK 1222082 · Chief Operating Officer · last filed 2025-12-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$887.3K
Companies
5
Total Filings
61
Lifetime Open-Market Net
-$25.78M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| URGN | Director | 2,000 | $29.72 | $59.4K | $0 | 8 | 2025-12-01 |
| IPSC | Director | — | $2.25 | — | $0 | 5 | 2025-06-16 |
| OLMA | Director | 83,876 | $9.87 | $827.9K | $0 | 7 | 2025-06-13 |
| Kite Pharma, Inc. (KITE) Delisted | Chief Operating Officer | 121,567 | — | — | -$25.78M | 38 | 2017-09-27 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | COO and CFO | — | — | — | $0 | 2 | 2009-11-18 |
Recent Filings · Page 5 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-07-26 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$495.9K | EDGAR |
| 2016-06-27 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$987.2K | EDGAR |
| 2016-04-06 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$486.5K | EDGAR |
| 2016-03-03 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$486.8K | EDGAR |
| 2016-02-04 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$92.7K | EDGAR |
| 2016-01-29 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$407.2K | EDGAR |
| 2015-12-29 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$602.1K | EDGAR |
| 2015-12-21 | Kite Pharma, Inc. (KITE) Delisted | Grant (A) | +18,500 | $0 | EDGAR |
| 2015-11-30 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$1.28M | EDGAR |
| 2015-11-12 | Kite Pharma, Inc. (KITE) Delisted | Mixed | — | -$393.2K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.